Table 1.
Descriptive statistics of the variables used in the analysis. For clarity, throughout the paper, categories pertaining to the same variable are grouped by color.
| Full Sample | T0 | T1 | T2 | T3 | T4 | |
|---|---|---|---|---|---|---|
| (%) | (%) | (%) | (%) | (%) | (%) | |
| Independent variables | ||||||
| Gender: Females | 65.82 | 66.67 | 58.54 | 73.33 | 67.11 | 64.20 |
| Gender: Males | 27.34 | 22.22 | 36.59 | 24.00 | 26.32 | 27.16 |
| Gender: Other | 6.84 | 11.11 | 4.88 | 2.67 | 6.58 | 8.64 |
| Age: 12–15 | 23.80 | 24.69 | 26.83 | 20.00 | 23.68 | 23.46 |
| Age: 16–17 | 48.86 | 45.68 | 50.00 | 50.67 | 47.37 | 50.62 |
| Age: 18–19 | 27.34 | 29.63 | 23.17 | 29.33 | 28.95 | 25.93 |
| Mother’s ed.: Uni | 25.57 | 17.28 | 34.15 | 26.67 | 28.95 | 20.99 |
| Mother’s ed.: HS | 39.75 | 43.21 | 35.37 | 45.33 | 38.16 | 37.04 |
| Mother’s ed.: No HS | 34.68 | 39.51 | 30.49 | 28.00 | 32.89 | 41.98 |
| No lyceum HS | 26.08 | 25.93 | 24.39 | 24.00 | 30.26 | 25.93 |
| Lyceum (ref: other HS) | 73.92 | 74.07 | 75.61 | 76.00 | 69.74 | 74.07 |
| Big city (>20,000 inhabitants) | 65.57 | 59.26 | 65.85 | 68.00 | 65.79 | 69.14 |
| Small city (<20,000 inhabitants) | 34.43 | 40.74 | 34.15 | 32.00 | 34.21 | 30.86 |
| North/center | 85.32 | 87.65 | 84.15 | 88.00 | 80.26 | 86.42 |
| South/islands | 14.68 | 12.35 | 15.85 | 12.00 | 19.74 | 13.58 |
| Social: Rarely | 4.30 | 3.70 | 7.32 | 2.67 | 1.32 | 6.17 |
| Social: Sometimes | 25.06 | 22.22 | 26.83 | 25.33 | 21.05 | 29.63 |
| Social: Often | 70.63 | 74.07 | 65.85 | 72.00 | 77.63 | 64.20 |
| News: Rarely | 40.00 | 32.10 | 43.90 | 33.33 | 47.37 | 43.21 |
| News: Sometimes | 42.53 | 49.38 | 42.68 | 48.00 | 35.53 | 37.04 |
| News: Often | 17.47 | 18.52 | 13.41 | 18.67 | 17.11 | 19.75 |
| Vaccinated: No | 7.59 | 7.41 | 7.32 | 2.67 | 13.16 | 7.41 |
| Vaccinated: Yes | 92.41 | 92.59 | 92.68 | 97.33 | 86.84 | 92.60 |
| T0: Control group | 20.51 | - | - | - | - | - |
| T1: Public good | 20.76 | - | - | - | - | - |
| T2: Private good | 18.99 | - | - | - | - | - |
| T3: Severe adverse effects | 19.24 | - | - | - | - | - |
| T4: Mild adverse effects | 20.51 | - | - | - | - | - |
| Mean | Mean | Mean | Mean | Mean | Mean | |
| Dependent variables | ||||||
| a.PC1 | 0.000 | 0.101 | −0.253 | 0.054 | 0.031 | 0.076 |
| a.PC2 | 0.000 | 0.104 | −0.192 | −0.061 | 0.007 | 0.173 |
| a.PC3 | 0.000 | 0.223 | −0.035 | −0.089 | −0.019 | −0.087 |
| b.PC1 | 0.000 | −0.196 | 0.048 | −0.079 | 0.157 | 0.073 |
| b.PC2 | 0.000 | −0.072 | 0.192 | 0.061 | −0.007 | −0.173 |
| b.PC3 | 0.000 | −0.054 | 0.108 | 0.017 | −0.125 | 0.047 |
| c.PC1 | 0.000 | −0.096 | 0.217 | −0.038 | −0.001 | −0.088 |
| c.PC2 | 0.000 | −0.016 | 0.005 | −0.148 | 0.013 | 0.135 |
| c.PC3 | 0.000 | −0.036 | −0.160 | 0.119 | 0.067 | 0.026 |
| d.PC1 | 0.000 | −0.101 | 0.253 | −0.054 | −0.031 | −0.076 |
| d.PC2 | 0.000 | 0.111 | −0.006 | −0.026 | −0.114 | 0.027 |
| d.PC3 | 0.000 | −0.223 | 0.035 | 0.089 | 0.019 | 0.087 |
| No. observations | 395 | 81 | 82 | 75 | 76 | 81 |